Evoq Remedies Q4 Results
- BSE: 543500
- NSE: -
- ISIN: INE0JVD01011
- Sector: Biotechnology & Drugs
BSE
4.69
0.09 (1.96%)
0.09 (1.96%)Volume4.00 K
Updated: Fri 13 Jun, 2025 | 10:15:00
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹11.76 Cr.(7743.03%)
- Operating Profit₹-0.65 Cr.(-62.00%)
- Profit After Tax₹1.71 Cr.(325.60%)
- Operating Margin-5.54%(-93.70%)
Note: Comparison is on YoY basis
Quarterly - Evoq Remedies Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | - | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 11.76 | - | N/A | 0.15 | 7743.03% |
| Selling/ General/ Admin Expenses Total | 0.05 | - | N/A | 0.02 | 176.06% |
| Depreciation/ Amortization | 0.04 | - | N/A | 0.00 | 1503.57% |
| Other Operating Expenses Total | 0.79 | - | N/A | 2.58 | -69.34% |
| Total Operating Expense | 12.41 | - | N/A | 1.86 | 565.60% |
| Operating Income | -0.65 | - | N/A | -1.71 | -62.00% |
| Net Income Before Taxes | 1.75 | - | N/A | 0.54 | 223.30% |
| Net Income | 1.71 | - | N/A | 0.40 | 325.60% |
| Diluted Normalized EPS | 0.69 | - | N/A | 0.27 | 152.06% |